Expoint โ€“ all jobs in one place
ื”ืžืงื•ื ื‘ื• ื”ืžื•ืžื—ื™ื ื•ื”ื—ื‘ืจื•ืช ื”ื˜ื•ื‘ื•ืช ื‘ื™ื•ืชืจ ื ืคื’ืฉื™ื

ื“ืจื•ืฉื™ื Site Microbiologist Lead ื‘-ื˜ื‘ืข ื‘-ื‘ืจื™ื˜ื ื™ื”

ืžืฆืื• ืืช ื”ื”ืชืืžื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจื›ื ืขื ืืงืกืคื•ื™ื ื˜! ื—ืคืฉื• ื”ื–ื“ืžื ื•ื™ื•ืช ืขื‘ื•ื“ื” ื‘ืชื•ืจ Site Microbiologist Lead ื‘-United Kingdom ื•ื”ืฆื˜ืจืคื• ืœืจืฉืช ื”ื—ื‘ืจื•ืช ื”ืžื•ื‘ื™ืœื•ืช ื‘ืชืขืฉื™ื™ืช ื”ื”ื™ื™ื˜ืง, ื›ืžื• Teva. ื”ื™ืจืฉืžื• ืขื›ืฉื™ื• ื•ืžืฆืื• ืืช ืขื‘ื•ื“ืช ื”ื—ืœื•ืžื•ืช ืฉืœืš ืขื ืืงืกืคื•ื™ื ื˜!
ื—ื‘ืจื” (1)
ืื•ืคื™ ื”ืžืฉืจื”
ืงื˜ื’ื•ืจื™ื•ืช ืชืคืงื™ื“
ืฉื ืชืคืงื™ื“ (1)
United Kingdom
ืขื™ืจ
ื ืžืฆืื• 2 ืžืฉืจื•ืช
12.05.2025
T

Teva Director Pipeline Immunology Asset Lead Global United Kingdom, England

Limitless High-tech career opportunities - Expoint

ืฉื™ืชื•ืฃ

ื”ืชื—ื‘ืจ/ื™ ื›ื“ื™ ืœื”ื’ื™ืฉ ืžื•ืขืžื“ื•ืช
ืชื™ืื•ืจ:
Developing GHEVO Strategies:Lead the creation and implementation of evidence generation plans to support the value proposition of pipeline immunology assets, ensuring alignment with regulatory and governance standards. Provide insights into...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื

ืžืฉืจื•ืช ื ื•ืกืคื•ืช ืฉื™ื›ื•ืœื•ืช ืœืขื ื™ื™ืŸย ืื•ืชืš

27.04.2025
T

Teva Corporate Affairs Lead United Kingdom, England, Wakefield

Limitless High-tech career opportunities - Expoint

ืฉื™ืชื•ืฃ

ื”ืชื—ื‘ืจ/ื™ ื›ื“ื™ ืœื”ื’ื™ืฉ ืžื•ืขืžื“ื•ืช
ืชื™ืื•ืจ:
You will develop and execute internal and external corporate communication and engagement strategies and plans, aligned with our global and regional priorities. You will serve as the communications business partner...
ืคืจื˜ื™ ื”ืžืฉืจื” ื”ืžืœืื™ื
ื‘ื•ืื• ืœืžืฆื•ื ืืช ืขื‘ื•ื“ืช ื”ื—ืœื•ืžื•ืช ืฉืœื›ื ื‘ื”ื™ื™ื˜ืง ืขื ืืงืกืคื•ื™ื ื˜. ื‘ืืžืฆืขื•ืช ื”ืคืœื˜ืคื•ืจืžื” ืฉืœื ื• ืชื•ื›ืœ ืœื—ืคืฉ ื‘ืงืœื•ืช ื”ื–ื“ืžื ื•ื™ื•ืช Site Microbiologist Lead ื‘ื—ื‘ืจืช Teva ื‘-United Kingdom. ื‘ื™ืŸ ืื ืืชื ืžื—ืคืฉื™ื ืืชื’ืจ ื—ื“ืฉ ื•ื‘ื™ืŸ ืื ืืชื ืจื•ืฆื™ื ืœืขื‘ื•ื“ ืขื ืืจื’ื•ืŸ ืกืคืฆื™ืคื™ ื‘ืชืคืงื™ื“ ืžืกื•ื™ื, Expoint ืžืงืœื” ืขืœ ืžืฆื™ืืช ื”ืชืืžืช ื”ืขื‘ื•ื“ื” ื”ืžื•ืฉืœืžืช ืขื‘ื•ืจื›ื. ื”ืชื—ื‘ืจื• ืœื—ื‘ืจื•ืช ืžื•ื‘ื™ืœื•ืช ื‘ืื–ื•ืจ ืฉืœื›ื ืขื•ื“ ื”ื™ื•ื ื•ืงื“ืžื• ืืช ืงืจื™ื™ืจืช ื”ื”ื™ื™ื˜ืง ืฉืœื›ื! ื”ื™ืจืฉืžื• ื”ื™ื•ื ื•ืขืฉื• ืืช ื”ืฆืขื“ ื”ื‘ื ื‘ืžืกืข ื”ืงืจื™ื™ืจื” ืฉืœื›ื ื‘ืขื–ืจืช ืืงืกืคื•ื™ื ื˜.